litlas
Log inCreate account

Irwin Lucki

Active 1982–2022

91
Papers
19,912
Citations
79
h-index
91
i10-index

Citations

Citations per year for Irwin Lucki1983: 4 citations1984: 8 citations1985: 19 citations1986: 14 citations1987: 16 citations1988: 16 citations1989: 7 citations1990: 15 citations1991: 14 citations1992: 21 citations1993: 16 citations1994: 17 citations1995: 31 citations1996: 22 citations1997: 46 citations1998: 53 citations1999: 53 citations2000: 85 citations2001: 122 citations2002: 191 citations2003: 190 citations2004: 267 citations2005: 245 citations2006: 246 citations2007: 263 citations2008: 289 citations2009: 282 citations2010: 301 citations2011: 261 citations2012: 193 citations2013: 203 citations2014: 173 citations2015: 152 citations2016: 120 citations2017: 110 citations2018: 99 citations2019: 416 citations2020: 441 citations2021: 333 citations2022: 272 citations2023: 154 citations2024: 248 citations2025: 98 citations2026: 1 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,919 citing papers, 32.4% of this breakdownChina: 412 citing papers, 7% of this breakdownCanada: 324 citing papers, 5.5% of this breakdownGermany: 299 citing papers, 5.1% of this breakdownUnited Kingdom: 262 citing papers, 4.4% of this breakdownFrance: 250 citing papers, 4.2% of this breakdownItaly: 227 citing papers, 3.8% of this breakdownBrazil: 198 citing papers, 3.3% of this breakdownJapan: 169 citing papers, 2.9% of this breakdownSpain: 146 citing papers, 2.5% of this breakdownNetherlands: 118 citing papers, 2% of this breakdownAustralia: 106 citing papers, 1.8% of this breakdown
0%32.4%Other 25.1%

Institutions

Fields

  • Neuroscience52.7%
  • Medicine24.8%
  • Biochemistry, Genetics and Molecular Biology11%
  • Psychology6.8%
  • Pharmacology, Toxicology and Pharmaceutics1.1%
  • Agricultural and Biological Sciences0.8%
  • Other2.8%

Topics

  • Neurotransmitter Receptor Influence on Behavior10.2%
  • Stress Responses and Cortisol8.2%
  • Tryptophan and brain disorders6.5%
  • Neuroscience and Neuropharmacology Research5.9%
  • Neuroendocrine regulation and behavior4.7%
  • Receptor Mechanisms and Signaling4.1%
  • Other60.4%

Coauthors

All papers

Open in search
  1. Assessing antidepressant activity in rodents: recent developments and future needs

    Authors: John F. Cryan, Athina Markou, Irwin Lucki - Trends in Pharmacological Sciences 2002 cited by 1,543

  2. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants

    Authors: Michael J. Detke, Michael R. Rickels, Irwin Lucki - Psychopharmacology 1995 cited by 1,434

  3. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test

    Authors: John F. Cryan, Rita J. Valentino, Irwin Lucki - Neuroscience & Biobehavioral Reviews 2005 cited by 1,118

  4. The spectrum of behaviors influenced by serotonin

    Authors: Irwin Lucki - Biological Psychiatry 1998 cited by 1,157

  5. 5-HT1A receptor function in major depressive disorder

    Authors: Jonathan Savitz, Irwin Lucki, Wayne C. Drevets - Progress in Neurobiology 2009 cited by 570

  6. Effects of diabetes on hippocampal neurogenesis: Links to cognition and depression

    Authors: Nancy Ho, Marilyn S. Sommers, Irwin Lucki - Neuroscience & Biobehavioral Reviews 2013 cited by 269

  7. High fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice

    Authors: Steven E. Arnold, Irwin Lucki, Bethany R. Brookshire, Gregory C. Carlson, Caroline A. Browne, Hala Kazi, Sookhee Bang, Bo‐Ran Choi, Yong Chen, Mary F. McMullen, Sangwon F. Kim - Neurobiology of Disease 2014 cited by 311

  8. Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth

    Authors: Michael J. Detke, Irwin Lucki - Behavioural Brain Research 1995 cited by 351

  9. Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants

    Authors: Caroline A. Browne, Irwin Lucki - Frontiers in Pharmacology 2013 cited by 284

  10. The role of serotonin receptor subtypes in treating depression: a review of animal studies

    Authors: Gregory V. Carr, Irwin Lucki - Psychopharmacology 2010 cited by 237

  11. A role for corticotropin-releasing factor signaling in the lateral habenula and its modulation by early-life stress

    Authors: Michael E. Authement, Ludovic D. Langlois, Ryan D. Shepard, Caroline A. Browne, Irwin Lucki, Haifa Kassis, Fereshteh S. Nugent - Science Signaling 2018 cited by 77

  12. Adult hippocampal neurogenesis: Regulation, functional implications, and contribution to disease pathology

    Authors: Darrick T. Balu, Irwin Lucki - Neuroscience & Biobehavioral Reviews 2008 cited by 384

  13. Dysregulation of the Lateral Habenula in Major Depressive Disorder

    Authors: Caroline A. Browne, Robert Hammack, Irwin Lucki - Frontiers in Synaptic Neuroscience 2018 cited by 98

  14. Kappa Opioid Receptor Antagonists as Potential Therapeutics for Stress-Related Disorders

    Authors: Moriah L. Jacobson, Caroline A. Browne, Irwin Lucki - The Annual Review of Pharmacology and Toxicology 2020 cited by 71

  15. The forced swimming test as a model for core and component behavioral effects of antidepressant drugs

    Authors: Irwin Lucki - Behavioural Pharmacology 1997 cited by 797

  16. Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice

    Authors: Irwin Lucki, Ashutosh Dalvi, Arthur J. Mayorga - Psychopharmacology 2001 cited by 508

  17. Mediation of the behavioral effects of ketamine and (2R,6R)-hydroxynorketamine in mice by kappa opioid receptors

    Authors: Hildegard A. Wulf, Caroline A. Browne, Carlos A. Zarate, Irwin Lucki - Psychopharmacology 2022 cited by 28

  18. NIDDK International Conference Report on Diabetes and Depression: Current Understanding and Future Directions

    Authors: Richard I. G. Holt, Mary de Groot, Irwin Lucki, Christine M. Hunter, Norman Sartorius, Sherita Hill Golden - Diabetes Care 2014 cited by 151

  19. The kappa opioid receptor antagonist aticaprant reverses behavioral effects from unpredictable chronic mild stress in male mice

    Authors: Moriah L. Jacobson, Hildegard A. Wulf, Caroline A. Browne, Irwin Lucki - Psychopharmacology 2020 cited by 35

  20. Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects

    Authors: Brian A. Hoshaw, Jessica E. Malberg, Irwin Lucki - Brain Research 2005 cited by 344

  21. Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment

    Authors: John F. Cryan, Michelle E. Page, Irwin Lucki - Psychopharmacology 2005 cited by 320

  22. HDAC6 Regulates Glucocorticoid Receptor Signaling in Serotonin Pathways with Critical Impact on Stress Resilience

    Authors: Julie Espallergues, Sarah L. Teegarden, Avin Veerakumar, Janette Boulden, Collin Challis, Jeanine Jochems, Michael Chan, Tess Petersen, Evan S. Deneris, Patrick Matthias, Chang-Gyu Hahn, Irwin Lucki, Sheryl G. Beck, Olivier Berton - Journal of Neuroscience 2012 cited by 144

  23. Corticotropin-releasing factor in the dorsal raphe nucleus: Linking stress coping and addiction

    Authors: Rita J. Valentino, Irwin Lucki, Elisabeth Van Bockstaele - Brain Research 2009 cited by 137

  24. Akt1 deficiency in schizophrenia and impairment of hippocampal plasticity and function

    Authors: Darrick T. Balu, Gregory C. Carlson, Konrad Talbot, Hala Kazi, Tiffany E. Hill‐Smith, Rachel M. Easton, Morris J. Birnbaum, Irwin Lucki - Hippocampus 2010 cited by 102